Asthma, a chronic disease characterized by recurrent breathlessness and wheezing, continues to be a significant global health concern. As healthcare professionals, it is crucial to stay abreast of the latest advancements in its management. This article seeks to review some of the recent advances in asthma management.
Biologic therapies, designed to target specific molecules involved in the inflammatory process of asthma, have emerged as a promising approach. Monoclonal antibodies such as Omalizumab, Mepolizumab, and Benralizumab have shown efficacy in reducing exacerbation rates and improving quality of life, particularly in severe eosinophilic asthma.
Smart inhalers represent a technological advancement in asthma management. These devices can monitor usage, provide reminders, and share data with healthcare providers, thus enhancing medication adherence and facilitating personalized care.
Fractional exhaled nitric oxide (FeNO) testing is a non-invasive method to measure airway inflammation, which can help in diagnosing and monitoring asthma. It is particularly useful in identifying patients with eosinophilic inflammation who may benefit from corticosteroid therapy.
Bronchial thermoplasty, a novel therapeutic procedure, involves the delivery of thermal energy to the airway wall in a series of bronchoscopy procedures. It has been shown to reduce severe exacerbations and improve asthma control in patients with severe refractory asthma.
These advancements in asthma management are transforming care and improving patient outcomes. As healthcare professionals, our role is to integrate these new approaches into our practice, based on individual patient needs and characteristics. Continuous education and awareness of these developments will ensure that we provide the best possible care to our patients with asthma.
1.
Health researchers discuss Medicaid cancer screening trends, best practices
2.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
3.
Approved BTK Inhibitor Without Covalent Bond for CLL.
4.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
5.
AI-based breast cancer risk technology receives FDA breakthrough device designation
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Innovative Solutions in Hematology for Specialists
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
5.
Evidence-Based Insights in Oncology for Specialists
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation